Science Weekly

Just Stop Oil, the climate activism group behind motorway blockades, petrol station disruption and tomato soup attacks on major artworks, has disbanded after staging a final action in London this weekend. To find out why the group has decided to hang up the famous orange high-vis, Madeleine Finlay hears from our environment correspondent Damien Gayle who has been covering Just Stop Oil since its inception. He explains how policy wins and policing crackdowns combined to bring the movement to a close, and what the future of climate activism could look like in its wake. Help support our independent journalism at theguardian.com/sciencepod

Madeleine Finlay and Ian Sample discuss three intriguing science stories from the week. From a hint at alien life on a distant planet to a clue in the search for answers over why colon cancer rates are rising in the under 50s, and news from scientists who claim to have found a colour no one has seen before. Help support our independent journalism at theguardian.com/sciencepod

The American biotech company Colossal Biosciences recently made headlines around the world with claims it had resurrected the dire wolf, an animal that went extinct at the end of the last ice age. But does what the company has done amount to ‘de-extinction’ or should we instead think of these pups as genetically modified versions of the grey wolves that exist today? Science correspondent Nicola Davis tells Madeleine Finlay about the process that created these wolves, how other companies are joining the effort to use genetic modification in conservation, and why some experts have serious ethical questions about bringing back species whose habitats no longer exist. Help support our independent journalism at theguardian.com/sciencepod

As a measles outbreak expands across the US, comments by health secretary Robert F Kennedy Jr have come under scrutiny. Kennedy has said that the best way to prevent measles is to get vaccinated – but he has also caused alarm among paediatricians, vaccine experts and lawmakers by promoting vitamin A and nutrition as treatments for measles and questioning the safety testing of the MMR vaccine. He also recently announced a US-led scientific effort to establish the cause of what he terms the ‘autism epidemic’, with some experts concerned that this study will support the widely discredited association between autism and vaccines. US health reporter Jessica Glenza tells Ian Sample, the Guardian’s science editor, how these mixed messages are already impacting scientific research.. Help support our independent journalism at theguardian.com/sciencepod

Robin McKie reflects on his 40 years as science editor for the Observer and tells Madeleine Finlay about the game-changing discoveries and scientific controversies that he’s reported on during that time. He describes how the discovery of the structure of DNA revolutionised science, what he learned about misinformation from the HIV/AIDS pandemic and why cold fusion and the millennium bug failed to live up to their hype.. Help support our independent journalism at theguardian.com/sciencepod

Switzerland is leading the world in purifying its water of micropollutants, a concoction of chemicals often found in bodies of water that look crystal clear. They include common medicines like antidepressants and antihistamines, but have unknown and potentially damaging consequences for human and ecosystem health. In the second of a two-part series, Phoebe Weston travels to Geneva to find out how the country has transformed its rivers from sewage-filled health hazards to pristine swimming spots. She tells Madeleine Finlay how a public health disaster in the 1960s spurred the government to act, and what the UK could learn from the Swiss about taking care of a precious national asset.. Help support our independent journalism at theguardian.com/sciencepod

The UK is known for its national parks: areas of outstanding natural beauty with rolling hills and crystal-clear streams and lakes. But research has shown that England’s most protected rivers are full of pharmaceuticals. In episode one of a two-part series, biodiversity reporter Phoebe Weston tells Madeleine Finlay about the problem of chemical pollution in our waterways, and how it could be contributing to what the World Health Organization has described as ‘the silent pandemic’ – antimicrobial resistance.. Help support our independent journalism at theguardian.com/sciencepod

Invertebrates don’t get the attention lavished on cute pets or apex predators, but these unsung heroes are some of the most impressive and resilient creatures on the planet. So when the Guardian opened its poll to find the world’s finest invertebrate, readers got in touch in their droves. A dazzling array of nominations have flown in for insects, arachnids, snails, crustaceans, corals and many more obscure creatures. Patrick Barkham tells Madeleine Finlay why these tiny creatures deserve more recognition, and three readers, Sandy, Nina and Russell, make the case for their favourites.. Help support our independent journalism at theguardian.com/sciencepod

While other diet fads come and go, the ultra low carbohydrate Keto diet seems to endure. But as scientists begin to understand how the diet works, more is also being discovered about its risks. To find out more, Madeleine Finlay speaks to Javier Gonzalez, professor in the department of health at the University of Bath, with a special interest in personal nutrition. He explains how the diet works, what it could be doing to our bodies and what could really be behind the weight loss people experience while on it. Help support our independent journalism at theguardian.com/sciencepod

The genetic testing firm 23andMe has filed for bankruptcy, another twist in the story of a company that promised a pioneering approach to precision health. Now users are scrambling to delete their personal data, with the future ownership of the firm uncertain. To understand the highs and lows of 23andMe’s journey, Madeleine Finlay hears from the Guardian US tech reporter and editor Johana Bhuiyan, and from Timothy Caulfield, a professor of law at the University of Alberta, who has a special interest in health and biotechnology. Help support our independent journalism at theguardian.com/sciencepod